about
Dynorphin, stress, and depressionImportance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptorsFormation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia30 years of dynorphins--new insights on their functions in neuropsychiatric diseasesBi-phasic intensity-dependent opioid-mediated neural amplitude changes in the chinchilla cochlea: partial blockade by an N-Methyl-D-Aspartate (NMDA)-receptor antagonistPersistent changes in spinal cord gene expression after recovery from inflammatory hyperalgesia: a preliminary study on pain memory.Peptide kappa opioid receptor ligands: potential for drug development.Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitizationDiscovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cordIncreased spinal prodynorphin gene expression in reinflammation-associated hyperalgesia after neonatal inflammatory insultProdynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition.Problems with using mechanisms to solve the problem of extrapolation.Effect of adenoviral delivery of prodynorphin gene on experimental inflammatory pain induced by formalin in ratsEstrogens Suppress Spinal Endomorphin 2 Release in Female Rats in Phase with the Estrous Cycle.Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system.Opioid regulation of spinal cord plasticity: evidence the kappa-2 opioid receptor agonist GR89696 inhibits learning within the rat spinal cordIncreased spinal dynorphin contributes to chronic nicotine-induced mechanical hypersensitivity in the rat.Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive ActivityThe permeation of dynorphin A 1-6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeabilityViral vector-based gene transfer for treatment of chronic pain.Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cordEvaluation of an on-capillary copper complexation methodology for the investigation of in vitro metabolism of dynorphin A 1-17Chapter 9 The dorsal horn and hyperalgesia.Various modifications of the amphipathic dynorphin A pharmacophore for rat brain bradykinin receptors.Structure-activity relationships of non-opioid [des-Arg(7)]-dynorphin A analogues for bradykinin receptors.Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction.Separation of dynorphin peptides by capillary electrochromatography using a polydiallyldimethylammonium chloride gold nanoparticle-modified capillary.Cyclic non-opioid dynorphin A analogues for the bradykinin receptors.Opioid precursor protein isoform is targeted to the cell nuclei in the human brain.
P2860
Q24650168-2D5B5E5F-1E2F-4E92-BCF4-EA6FE0AD3525Q27011537-BE7CE2B6-B30C-4B78-8172-8A6C7927381BQ28568886-BE70D1A2-4080-419F-92F5-3C94320DAB22Q30481450-7043707E-6819-4A6D-9599-5365EE419B76Q30491472-115C6D6B-4102-45D7-B4DC-82F71083CDBDQ33325626-D52F9498-F44E-40B1-9B2D-57FB14DDA7CAQ33442900-C0E8CE5E-8C89-496F-B11A-663D176C45F4Q33553754-6A22FC78-9584-43BC-A328-55517B69AC20Q33613843-BBA3B991-4EF8-4A63-8F4C-4A58FB0C7AF9Q33727378-EAAB1F59-939D-489E-A802-351ED2800FBFQ34300816-B16147EE-1948-43D8-BC3E-A8AE1B6ABC1EQ34552064-90CC8C80-44F2-4128-96AA-1CAFBB7B5F22Q34824317-BE69626E-6AC9-48F0-A972-4151FE475A29Q35016982-64C68838-317E-45B6-9183-9A78BABC48B9Q36074349-A50B9A57-7A83-450C-B2CC-DF92AF8B0CB5Q36092808-4D57C92A-A9F5-48E5-B7D1-60FA3FC6FE42Q36281799-F7B50FE2-CED7-48CA-931E-C5A473AC649BQ36320274-6839649E-2E8B-48E1-B397-2D0BA5F8ABCDQ36328714-4DBC1B44-AC28-4659-A1CF-3A2051C07D74Q36431999-89EFB0F5-C938-4D23-AA11-6B611247800CQ36520837-2EE6EC80-F02C-4599-B8BF-9F486DFEEE67Q36787828-EE85DF79-6E24-4222-87BA-9F5E0A26C6BBQ36917570-8B0601FD-BCE6-4DE3-8287-D747629A55B7Q37096685-768A36F1-5862-4754-8AD0-EFFC8CBB2F19Q39906178-9F119226-8681-4694-B90C-359D9CDA0E53Q41637178-80EA0707-0CF6-4710-AB1E-F55D7C866305Q41827415-04630801-9D79-4CBB-BA30-404D85750A41Q42123305-078DD368-A6B0-4263-85C0-AFD5031775EAQ42325603-AD87AB4B-C83B-471E-829A-52C2AD5F5AD6Q44340829-621FB64B-7D0D-4E71-A2AB-55E88ABE546FQ44341308-AAA045ED-2DD9-4C3C-9A34-56784D0BCFFD
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Neuropathic pain: the paradox of dynorphin.
@ast
Neuropathic pain: the paradox of dynorphin.
@en
type
label
Neuropathic pain: the paradox of dynorphin.
@ast
Neuropathic pain: the paradox of dynorphin.
@en
prefLabel
Neuropathic pain: the paradox of dynorphin.
@ast
Neuropathic pain: the paradox of dynorphin.
@en
P2093
P1476
Neuropathic pain: the paradox of dynorphin.
@en
P2093
P304
P577
2001-08-01T00:00:00Z